Galapagos reported EUR1.86B in Market Capitalization this September of 2025, considering the latest stock price and the number of outstanding shares.


Market Capitalization Change Date
argenx SE EUR 28.69B 4.16B Jun/2025
AstraZeneca GBP 215.51B 41B Jun/2025
Biogen USD 18.41B 1.62B Jun/2025
Genmab DKK 80.88B 7.82B Jun/2025
Gilead Sciences USD 137.91B 1.77B Jun/2025
GlaxoSmithKline GBP 56.24B 4.11B Jun/2025
GRIFOLS EUR 6.33B 1.14B Jun/2025
Hikma Pharmaceutical GBP 4.42B 226.35M Dec/2024
Incyte USD 13.18B 1.46B Jun/2025
Merck EUR 47.83B 7.27B Jun/2025
Neurocrine Biosciences USD 12.44B 1.5B Jun/2025
Novartis CHF 256.18B 64.49B Jun/2025
Sanofi EUR 100.06B 25.78B Jun/2025
Vertex Pharmaceuticals USD 114.33B 10.31B Jun/2025